类风湿性关节炎
药物输送
药品
超分子化学
互变异构体
材料科学
生物医学工程
化学
医学
纳米技术
药理学
有机化学
内科学
分子
作者
Hao Li,Yuanning Lyu,Ruinan Wang,Hong Yu,Mingxin Lin,Zhuo Li,Yanlin Zhong,Puyi Sheng,Kunyu Zhang,Wei‐Ming Liao,Liming Bian
标识
DOI:10.1016/j.bioactmat.2025.07.039
摘要
Rheumatoid arthritis (RA) is a major autoimmune disease characterized by significant joint inflammation and bone destruction. Many first-line RA treatment drugs such as methotrexate (MTX) have limited solubility in major solvents and are difficult to be delivered to RA joints in a sustained manner. Meanwhile, the efficient co-delivery of osteoinductive ions such as magnesium ions (Mg 2+ ) for RA treatment is also challenging due to the uncontrolled burst release. By capitalizing on the enhanced supramolecular interactions of cyanuric acid (CYA) upon the pH-induced keto-enol tautomerization, a supramolecular hydrogel (Gel-MTX/Mg) with efficient co-delivery of MTX and Mg 2+ is proposed. This hydrogel features pH-responsive on-demand release of MTX and Mg 2+ in RA joints triggered by the pathological pH-induced keto-enol tautomerization of CYA. The release of MTX and Mg 2+ from the Gel-MTX/Mg hydrogel induces anti-inflammatory M2 macrophage polarization, inhibits osteoclast differentiation, and enhances osteoblastic differentiation. Furthermore, RNA-seq results reveal that the Gel-MTX/Mg hydrogel promotes the enrichment of signaling pathways related to anti-inflammatory and bone-remodeling activities. One-time intra-articular administration of the Gel-MTX/Mg hydrogel significantly suppresses inflammation symptoms and protects bone and cartilage in a rat model. This supramolecular hydrogel that is capable of simultaneously delivering both therapeutic drugs and ions in response to pathological conditions has promising potential for the treatment of RA and other inflammatory and bone-degenerative diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI